Stockreport

CorMedix Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

CorMedix Inc.  (CRMD) 
NASDAQ:AMEX Investor Relations: cormedix.com
PDF ? Q4 2024 Net Revenue of $31.2mm; 2024 Net Revenue of $43.5mm ? ? Q4 Net Income of $13.5mm and Adjusted EBITDA of $15.3mm ? ? Conference Call Scheduled for Today a [Read more]